Martina Bertschinger

6PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma.

|Jul 15, 2026
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma.

|Jun 26, 2026
Influence of PPM1D Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients.

|Mar 28, 2026
Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation.

Pinar Horum, Katja Seipel, Inna Shaforostova

|Mar 28, 2026
Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab.

Maeva Ullmann, Katja Seipel, Henning Nilius

|Feb 27, 2026
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era.

Julia Bee, Inna Shaforostova, Michèle Hoffmann

Pageof 1

Frequent Collaborators

6 joint publications

Katja Seipel

6 joint publications

Ulrike Bacher

6 joint publications

Thomas Pabst

3 joint publications

Henning Nilius